The corresponding AUC values were 0.585, 0.598, 0.612, 0.559, 0.576, 0.587, 0.580, and 0.435, respectively, indicating that M, NLR, MLR, PLR, SII, PIV, and PNI may be associated with the efficacy of first‐line ICIs treatment in patients with advanced NSCLC, while ALB was not (Figures 3 and 4). The gene discussed is ALB; the disease is non-small cell lung carcinoma.